Rumble Boxing teams up with MJFF for Parkinson’s Awareness Month
Rumble Boxing, a U.S. fitness brand, is partnering for the second year with Team Fox, the grassroots fundraising community…
Articles by Andrea Lobo
Trial of VQ-101 for patients with GBA gene mutations begins dosing
The first patient has been dosed in a first-in-human trial testing Vanqua Bio’s VQ-101 as an oral therapy for…
NeuroVigil launches portable device to measure brain electrical activity
NeuroVigil has launched its iBrain personal brain monitor — an investigational portable device that can noninvasively record the brain’s…
NIH $1.9M research grant will fund detailed study of amyloid fibrils
A five-year project funded by a National Institutes of Health (NIH) research grant totaling nearly $1.9 million will study amyloid…
AI platform will design precision Parkinson’s, neurological therapies
Manifest Technologies has completed initial funding and a partnership with Johnson & Johnson to apply its artificial intelligence…
Produodopa available to treat advanced Parkinson’s in Scotland
Produodopa (foslevodopa/foscarbidopa; also known as ABBV-951), a continuous infusion formulation of levodopa/carbidopa, will be available to advanced Parkinson’s…
Investigational Parkinson’s therapy ALX-001 advances to Phase 2 trial
Allyx Therapeutics will advance into Phase 2 clinical development of ALX-001, its investigational therapy for neurodegenerative conditions, in people…
Fosgonimeton shows potential as dementia treatment, Athira says
Athira Pharma’s fosgonimeton (ATH-1017) shows promise as a therapy for neurodegenerative conditions including Parkinson’s disease, according to data presented…
Treatment to protect mitochondria may enter clinical trials this year
An experimental therapy called ASHA-091, which was seen to restore normal mitochondria function and possibly be disease modifying…
Risvodetinib shows potential to slow disease progression in clinical trial
Risvodetinib, an oral therapy being developed by Inhibikase Therapeutics for Parkinson’s disease, appears to stabilize disease status…